MiR-22 Suppresses BMP7 in the Development of Cirrhosis

Cellular Physiology and Biochemistry

Volumn 36, Issue 3, 2015, Pages 1026-1036

  Ji, Dong ^a   Li, Bing ^a   Shao, Qing ^a   Li, Fan ^a   Li, Zhongbin ^a   Chen, Guofeng ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Antisense; Bone morphogenic protein 7 (BMP7); Carbon tetrachloride (CCl 4 ); Cirrhosis; MicroRNAs; miR 22

Indexed keywords

MICRORNA 22; OSTEOGENIC PROTEIN 1; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; BMP7 PROTEIN, HUMAN; CARBON TETRACHLORIDE; LUCIFERASE; MICRORNA; MIRN22 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM RETENTION; UPREGULATION; ADMINISTRATION AND DOSAGE; ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMICALLY INDUCED; DEPENDOPARVOVIRUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEPG2 CELL LINE; HYPERTENSION, PORTAL; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; REPORTER GENE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ADULT; ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CARBON TETRACHLORIDE; DEPENDOVIRUS; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC VECTORS; HEP G2 CELLS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; SIGNAL TRANSDUCTION;

EID: 84933513500     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430276     Document Type: Article

References (46)

1. Hirschfield GM, Gershwin ME: The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 2013;8:303-330.
2. Invernizzi P, Selmi C, Gershwin ME: Update on primary biliary cirrhosis. Dig Liver Dis 2010;42:401-408.
3. Selmi C, Lleo A, Pasini S, Zuin M, Gershwin ME: Innate immunity and primary biliary cirrhosis. Curr Mol Med 2009;9:45-51.
4. Tangkijvanich P, Yee HF, Jr: Cirrhosis-can we reverse hepatic fibrosis? Eur J SurgS uppl 2002:100-112.
5. Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME: Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010;7:1-10.
6. Chuang YH, Ridgway WM, Ueno Y, Gershwin ME: Animal models of primary biliary cirrhosis. Clin Liver Dis 2008;12:333-347; i.x.
7. Concepcion AR, Medina JF: Approaches to the pathogenesis of primary biliary cirrhosis through animal models. Clin Res Hepatol Gastroenterol 2012;36:21-28.
8. Tsuneyama K, Moritoki Y, Kikuchi K, Nakanuma Y: Pathological features of new animal models for primary biliary cirrhosis. Int J Hepatol 2012;2012:403954.
9. Leung PS, Yang GX, Dhirapong A, Tsuneyama K, Ridgway WM, Gershwin ME: Animal models of primary biliary cirrhosis: Materials and methods. Methods Mol Biol 2012;900:291-316.
10. Wang J, Yang GX, Tsuneyama K, Gershwin ME, Ridgway WM, Leung PS: Animal models of primary biliary cirrhosis. Semin Liver Dis 2014;34:285-296.
11. Baghy K, Iozzo RV, Kovalszky I: Decorin-tgfbeta axis in hepatic fibrosis and cirrhosis. J Histochem Cytochem 2012;60:262-268.
12. Massague J: Tgfbeta signalling in context. Nat Rev Mol Cell Biol 2012;13:616-630.
13. Lan HY, Chung AC: Transforming growth factor-beta and smads. Contrib Nephrol 2011;170:75-82.
14. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, Gittes GK: M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A 2014;111:E1211-1220.
15. Liu G, Cheng J, Guan G, Jia Z: Renal lymph circulation blockage alters the epithelial cell phenotype and tubular integrity: Role of distinct regulation of bmp7 and tgf-beta/smads signaling pathway. Int Urol Nephrol 2014;46:1239-1246.
16. Khan I, Agarwal P, Thangjam GS, Radhesh R, Rao SG, Kondaiah P: Role of tgf-beta and bmp7 in the pathogenesis of oral submucous fibrosis. Growth Factors 2011;29:119-127.
17. Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, ten Dijke P, van der Pluijm G: Tgf-beta and bmp7 interactions in tumour progression and bone metastasis. Clin Exp Metastasis 2007;24:609-617.
18. Wang S, Hirschberg R: Bmp7 antagonizes tgf-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 2003;284:F1006-1013.
19. Shen B, Liu X, Fan Y, Qiu J: Macrophages regulate renal fibrosis through modulating tgfbeta superfamily signaling. Inflammation 2014;37:2076-2084.
20. Li B, Shao Q, Ji D, Li F, Chen G: Mesenchymal stem cells mitigate cirrhosis through bmp7. Cell Physiol Biochem 2015;35:433-440.
21. Wang S, Hyun J, Youn B, Jung Y: Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation. Radiat Res 2013;179:69-75.
22. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-23347.
23. Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL, Ikeda K: Adenovirus-mediated expression of bmp-7 suppresses the development of liver fibrosis in rats. Gut 2007;56:706-714.
24. Sugimoto H, Yang C, LeBleu VS, Soubasakos MA, Giraldo M, Zeisberg M, Kalluri R: Bmp-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 2007;21:256-264.
25. Jones CN, Tuleuova N, Lee JY, Ramanculov E, Reddi AH, Zern MA, Revzin A: Cultivating hepatocytes on printed arrays of hgf and bmp7 to characterize protective effects of these growth factors during in vitro alcohol injury. Biomaterials 2010;31:5936-5944.
26. O'Loughlin AJ, Woffindale CA, Wood MJ: Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 2012;12:262-274.
27. Pant S, Hilton H, Burczynski ME: The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012;83:1484-1494.
28. Bobrie A, Colombo M, Raposo G, Thery C: Exosome secretion: Molecular mechanisms and roles in immune responses. Traffic 2011;12:1659-1668.
29. Zhou WC, Zhang QB, Qiao L: Pathogenesis of liver cirrhosis. World J Gastroenterol 2014;20:7312-7324.
30. Xin X, Zhang Y, Liu X, Xin H, Cao Y, Geng M: Microrna in hepatic fibrosis and cirrhosis. Front Biosci 2014;19:1418-1424.
31. Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag M, Kolanowska M, Kotlarek M, Gornicka B, Koperski L, Niewinski G, Krawczyk M, Jazdzewski K: Next generation sequencing reveals microrna isoforms in liver cirrhosis and hepatocellular carcinoma. Int J Biochem Cell Biol 2014;53:208-217.
32. Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC, Chalasani N: Relationship between differential hepatic microrna expression and decreased hepatic cytochrome p450 3a activity in cirrhosis. PLoS One 2013;8:e74471.
33. Chen YJ, Zhu JM, Wu H, Fan J, Zhou J, Hu J, Yu Q, Liu TT, Yang L, Wu CL, Guo XL, Huang XW, Shen XZ: Circulating micrornas as a fingerprint for liver cirrhosis. PLoS One 2013;8:e66577.
34. Waidmann O, Koberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B: Serum microrna-122 predicts survival in patients with liver cirrhosis. PLoS One 2012;7:e45652.
35. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, Mao TK, Coppel RL, Ansari AA, Gershwin ME: Primary biliary cirrhosis is associated with altered hepatic microrna expression. J Autoimmun 2009;32:246-253.
36. Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF: Aberrant hepatic microrna expression in nonalcoholic fatty liver disease. Cell Physiol Biochem 2014;34:1983-1997.
37. Gong XH, Chen C, Hou P, Zhu SC, Wu CQ, Song CL, Ni W, Hu JF, Yao DK, Kang JH, Zhu L: Overexpression of mir-126 inhibits the activation and migration of hscs through targeting crk. Cell Physiol Biochem 2014;33:97-106.
38. Long J, Badal SS, Wang Y, Chang BH, Rodriguez A, Danesh FR: Microrna-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney. J Biol Chem 2013;288:36202-36214.
39. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A: Integrative microrna and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008;3:e3740.
40. Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis b surface antigen. Science 1980;209:497-499.
41. Khan IF, Hirata RK, Russell DW: Aav-mediated gene targeting methods for human cells. Nat Protoc 2011;6:482-501.
42. Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani JG, Alauddin MM, Pasqualini R, Arap W: Design and construction of targeted aavp vectors for mammalian cell transduction. Nat Protoc 2007;2:523-531.
43. Grieger JC, Choi VW, Samulski RJ: Production and characterization of adeno-associated viral vectors. Nat Protoc 2006;1:1412-1428.
44. Jiang X, Ren Y, Williford JM, Li Z, Mao HQ: Liver-targeted gene delivery through retrograde intrabiliary infusion. Methods Mol Biol 2013;948:275-284.
45. Xiao X, Guo P, Prasadan K, Shiota C, Peirish L, Fischbach S, Song Z, Gaffar I, Wiersch J, El-Gohary Y, Husain SZ, Gittes GK: Pancreatic cell tracing, lineage tagging and targeted genetic manipulations in multiple cell types using pancreatic ductal infusion of adeno-associated viral vectors and/or cell-tagging dyes. Nat Protoc 2014;9:2719-2724.
46. Thomas M, Rieger JK, Kandel BA, Klein K, Zanger UM: Targeting nuclear receptors with lentivirus-delivered small rnas in primary human hepatocytes. Cell Physiol Biochem 2014;33:2003-2013.